Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
36.5M
-
Shares change
-
+1.14M
-
Total reported value, excl. options
-
$185M
-
Value change
-
+$4.6M
-
Put/Call ratio
-
0.07
-
Number of buys
-
40
-
Number of sells
-
-31
-
Price
-
$5.08
Significant Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q1 2016
99 filings reported holding LBIO - LION BIOTECHNOLOGIES INC - COM as of Q1 2016.
LION BIOTECHNOLOGIES INC - COM (LBIO) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.5M shares
.
Largest 10 shareholders include FMR LLC (5.54M shares), venBio Select Advisor LLC (3.13M shares), PERCEPTIVE ADVISORS LLC (2.79M shares), RS INVESTMENT MANAGEMENT CO LLC (2.69M shares), ACUTA CAPITAL PARTNERS, LLC (2.5M shares), FRANKLIN RESOURCES INC (2.18M shares), Broadfin Capital, LLC (2.11M shares), BlackRock Fund Advisors (1.78M shares), VANGUARD GROUP INC (1.63M shares), and QVT Financial LP (1.6M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.